China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
Proposed Rio Tinto–Glencore Merger Faces China Regulatory Hurdles and Asset Sale Pressure 
Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years 
Lululemon Founder Chip Wilson Escalates Proxy Fight to Remove Advent From Board 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
Valentino Garavani Dies at 93, Leaving Behind the Timeless Legacy of Valentino Red 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
Baidu Shares Rise in Hong Kong After Apollo Go Robotaxi Launch in Abu Dhabi 
Syrah Resources and Tesla Extend Deadline on Graphite Supply Dispute to March 
BRANFORD, Conn., April 26, 2017 -- CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in non-invasive monitoring of cerebral oxygenation, announces that it will report financial results for the first quarter of 2017 on Wednesday, May 3, 2017, prior to the market’s opening. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. Eastern time that day.
Conference call dial-in information is as follows:
- U.S. callers: (866) 239-5859
- International callers: (702) 495-1913
Individuals interested in listening to the live conference call via the Internet may do so by logging on to the Company's website: www.casmed.com.
A telephone replay will be available from 1:00 p.m. Eastern time on May 3, 2017, through 11:59 p.m. Eastern time on May 17, 2017. Replay dial-in information is as follows:
- U.S. callers: (855) 859-2056
- International callers: (404) 537-3406
- Conference ID number (U.S. and international): 6276331
- The replay will also be available at www.casmed.com.
About CASMED® – Monitoring What's Vital
CASMED products are designed to provide unique non-invasive monitoring solutions that are vital to patient care. The Company's FORE-SIGHT® Cerebral Oximeters provide a highly accurate, non-invasive measurement of tissue oxygenation in the brain. Direct monitoring of tissue oxygenation can provide a superior and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygen in the brain and empower them to improve patient care. In addition to FORE-SIGHT oximeters and accessories, the Company also provides proprietary non-invasive blood pressure monitoring solutions for OEM use. For further information regarding CASMED, visit the Company's website at www.casmed.com.
Company Contacts
CAS Medical Systems, Inc.
Jeffery A. Baird
Chief Financial Officer
(203) 315-6303
[email protected]
Investors
LHA
Bruce Voss / Jody Cain
(310) 691-7100
[email protected]
[email protected]
@LHA_IR_PR
